日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study

改良版 FOLFOXIRI 联合帕尼单抗一线治疗 RAS/BRAF 野生型转移性结直肠癌:III 期 TRIPLETE 研究的最终结果

Conca, Veronica; Rossini, Daniele; Antoniotti, Carlotta; Lonardi, Sara; Pietrantonio, Filippo; Moretto, Roberto; Antonuzzo, Lorenzo; Randon, Giovanni; Lavacchi, Daniele; Pozzo, Carmelo; Marmorino, Federica; Bergamo, Francesca; Tamburini, Emiliano; Passardi, Alessandro; Fazio, Roberta; Murgioni, Sabina; Borelli, Beatrice; Buonadonna, Angela; Germani, Marco Maria; Formica, Vincenzo; Carullo, Martina; Bordonaro, Roberto; Aprile, Giuseppe; Zaniboni, Alberto; Masi, Gianluca; Boni, Luca; Cremolini, Chiara

REV7 associates with ATRIP and inhibits ATR kinase activity

REV7 与 ATRIP 结合并抑制 ATR 激酶活性

Megan Biller,Sara Kabir,Sarah Nipper,Sydney Allen,Yara Kayali,Skyler Kuncik,Hiroyuki Sasanuma,Pei Zhou,Cyrus Vaziri,Junya Tomida

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

在小鼠 COVID-19 模型中发现具有协同抗病毒功效的 SARS-CoV-2 PLpro 抑制剂和 RIPK1 抑制剂

Shan, Hengyue; Zhou, Yuzheng; Qin, Ying; Guo, Taijie; Zhang, Xiao; Xiang, Huaijiang; He, Qinyang; Shi, Chen; Li, Dekang; Liu, Jingli; Qi, Chunting; Chen, Shi; Dong, Jiajia; Xu, Gang; Li, Ying; Zhang, Zheng; Tan, Li

RIPK3 Orchestrates Scar-Associated Macrophage Dysfunction to Drive Pulmonary Fibrosis

RIPK3 调控瘢痕相关巨噬细胞功能障碍以驱动肺纤维化

Yang, Tao; Li, Xiao; Lei, Shuyue; Li, Qingqing; Zhang, Yi; Hui, Zhizhen; Ren, Jinjin; Yang, Xuelian; Yang, Xiaoqian; Feng, Chunlan; Xu, Yousheng; Zhao, Dongxin; Tang, Wei

NRIP1 disrupts ERα signal in Sjögren's disease via AQP5 suppression and MYC-driven salivary dysfunction

NRIP1通过抑制AQP5和MYC驱动的唾液功能障碍,干扰干燥综合征中的ERα信号通路。

Chen, Bo; Pathak, Janak L; Qin, Xiuni; Li, Xueyang; Mao, Tianjiao; Chen, Xi; Wei, Wei; Watanabe, Nobumoto; Wang, Lijing; Mayo, Kevin H; Di, Jun; Huo, Yongliang; Li, Xiaomeng; Li, Jiang

Bilirubin directly activates RIPK3 to induce non-classical necroptosis.

胆红素直接激活RIPK3,诱导非经典坏死性凋亡。

Xue Qian, Ma Xi, Chen Ziyuan, Ge Feifei, Wu Jiawen, Bao Wenhao, Zhou Li, Yi Wei, Wu Min, Liao Siyan, Xu Wenwen, He Rongrong, Feng Jingcheng, Hu Yameng, Chen Xi, Wu Xintian, Yan Ding, Tang Daolin, Chen Xin, Liu Jinbao

Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke.

用于缺血性中风中靶向抑制RIPK1-PANoptosome的氧化还原调节巨噬细胞生物混合纳米平台。

Jiang Wenhui, Xia Chundongqiu, Cui Zhimeng, Shi Lanhao, Feng Wei, Chen Yu, Zhang Jun

RIPK3-driven phosphorylation of MFN2 orchestrates endoplasmic reticulum-mitochondria interaction and cardiomyocyte stress responses.

RIPK3 驱动的 MFN2 磷酸化协调内质网-线粒体相互作用和心肌细胞应激反应。

Wang Yu, Xu Tao, Li Qi, Ye Lin, Wang Peiyan, Wang Puhan, Song Yihan, Ao Xiang, Wang Jianxun, Ding Wei

USP25 regulates atherosclerosis by restricting RIPK1-mediated inflammatory responses.

USP25 通过限制 RIPK1 介导的炎症反应来调节动脉粥样硬化。

Su Xian, Zhou Bincheng, Xu Yanqi, Du Xue, Chen Jiaqing, Yin Maojin, Miao Xiaomin, Zhao Ying, Wang Deqi, Zhu Zhenhu, Li Zhongding, Cai Fang, Wang Wei, Wu Gaojun, Huang Jingyong, Song Weihong, Wang Xu

Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1.

腺苷代谢清除通过促进 RIPK1 的精氨酸甲基化来维持肝脏稳态。